Tweetovi

Blokirali ste korisnika/cu @immusoft

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @immusoft

  1. Poništi
  2. 10. ruj 2019.

    Immusoft's Chief Development Officer, Dr. Scott McIvor, to present at to discuss Sleeping Beauty-Engineered B lymphocytes on the ISP Platform 9/14/2019

    Poništi
  3. 18. srp 2019.
    Poništi
  4. 17. lis 2018.

    Pleased to announce today that Immusoft has received Rare Pediatric Disease Designation for treatment of MPS I.

    Poništi
  5. 5. ruj 2018.

    Excited to announce receipt of $3.5 million SBIR grant. It will help us expand our work in MPS I and further explore modalities for delivering proteins across the blood-brain barrier.

    Poništi
  6. 10. srp 2018.

    We're thrilled to announce that internationally known immunologist, Jason Fontenot, Ph.D., has joined our leadership team as Chief Scientific Officer.

    Poništi
  7. 6. lip 2018.

    Excited and pleased to be a part of Michigan. As always, has brought together an impressive group. We look forward to having the chance to speak about our approach and technology.

    Poništi
  8. 15. svi 2018.

    It's International MPS Awareness Day! Wishing all the brave MPS patients and their loved ones the best. It's a privilege to pursue our work in the hope of treating and improving the lives of children with MPS I.

    Poništi
  9. 2. svi 2018.

    Pleased to have been granted Orphan Drug Designation to treat MPS I, the first indication in our pipeline.

    Poništi
  10. 29. sij 2018.

    Proud to be a winner of the Most Promising Company Award from the Precision Medicine World Conference. Thanks for the honor.

    Poništi
  11. 5. sij 2018.

    Excited to announce closing the first part of Series B and Sean Ainsworth coming on board as CEO.

    Poništi
  12. 4. svi 2016.

    Our ideas and process are covered in the May issue of -- Patient, Heal Thyself:

    Poništi
  13. proslijedio/la je Tweet
    30. ožu 2016.

    In our latest Q&A, Matthew Scholz discusses how DGI's technology expands & enhances 's platform:

    Poništi
  14. 8. ožu 2016.

    Excited to announce Discovery Genomics acquisition, bringing us great people and transposon system license.

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·